Abstract Erythrolysis occurs in the clot after intracerebral hemorrhage (ICH), and the release of hemoglobin causes brain injury, but it is unclear when such lysis occurs. The present study examined early erythrolysis in rats. ICH rats had an intracaudate injection of 100 μl autologous blood, and sham rats had a needle insertion. All rats had T2 and T2* magnetic response imaging (MRI) scanning, and brains were used for histology and CD163 (a hemoglobin scavenger receptor) and DARPP-32 (a neuronal marker) immunohistochemistry. There was marked heterogeneity within the hematoma on T2* MRI, with a hyperintense or isointense core and a hypointense periphery. Hematoxylin and eosin staining in the same animals showed significant erythrolysis in the core with the formation of erythrocyte ghosts. The degree of erythrolysis correlated with the severity of perihematomal neuronal loss. Perihematomal CD163 was increased by day 1 after ICH and may be involved in clearing hemoglobin caused by early hemolysis. Furthermore, ICH resulted in more severe erythrolysis, neuronal loss, and perihematomal CD163 upregulation in spontaneously hypertensive rats compared to Wistar-Kyoto rats. In conclusion, T2*MRI-detectable early erythrolysis occurred in the clot after ICH and activated CD163. Hypertension is associated with enhanced erythrolysis in the hematoma.
Introduction
Hematoma lysis, hemoglobin release/degradation, and brain iron overload cause brain injury after intracerebral hemorrhage (ICH) [1] [2] [3] [4] [5] . Previous studies have shown that erythrocyte lysis results in brain edema, neuronal death, and neurological deficits in animal models [6] [7] [8] . However, the natural history of erythrolysis in the clot following ICH has not been well examined and the extent to which early erythrolysis occurs in the hematoma not determined.
Magnetic response imaging (MRI) is useful to detect the intracerebral bleeding and has been used in hyperacute ICH [9, 10] . Susceptibility-weighted imaging (SWI) and gradient recalledecho sequence (i.e., T2* sensitive) MRI show heterogeneity of signal within the hematoma after ICH, and this has been attributed to differences in hemoglobin oxygen status [9, 10] . However, it is possible that T2* MRI or SWI is detecting areas of erythrolysis within the hematoma and loss of hemoglobin.
If early erythrolysis occurs in the hematoma, it may cause perihematomal neuronal loss and upregulate CD163, a hemoglobin scavenger receptor. CD163 is mainly expressed on macrophages/microglia, and it plays a major role in scavenging free hemoglobin released during erythrolysis [11, 12] . In ICH patients, the expression of CD163 increased around the hematoma [13] , and our recent study found that CD163-positive cells are present and are significantly increased in the hematoma in the first 24 h in a pig ICH model [14] .
Hypertension is the major cause of spontaneous ICH, and it is associated with more severe neurological deficits after ICH [15] . Our previous study found more perihematomal neuronal death in spontaneously hypertensive rats (SHRs) compared to Wistar-Kyoto (WKY) rats after ICH [16] . In hypertensive animals and humans, impairments in erythrocyte deformability have been described [17, 18] , but it is unclear whether erythrolysis after ICH is affected by hypertension.
Based on the previously mentioned, the present study used T2* MRI and brain histology to examine early erythrolysis in the hematoma in rats. The role of hypertension in early erythrolysis, neuronal death, and CD163 upregulation was also determined.
Methods

Animal Preparation and Intracerebral Infusion
Animal use protocols were approved by the University of Michigan Committee on the Use and Care of Animals. Male Sprague-Dawley rats (weight 275-300 g), SHR (mean arterial blood pressure 145 ± 8 mmHg) and WKY rats (103 ± 10 mmHg) at 12 weeks of age (Charles River Laboratory, Portage, MI) were used in this study. Blood pressure was measured using a noninvasive tail cuff pressure system. No blood pressure changes were found after ICH.
The rats were anesthetized with pentobarbital (45 mg/kg) intraperitoneally. A feedback-controlled heating pad was used for maintaining core temperature at 37°C. The right femoral artery was catheterized for continuous blood pressure monitoring, blood collection, and blood gas monitoring. The rats were positioned in a stereotactic frame and received an injection of 100 μl blood into the right basal ganglia (coordinates 0.2 mm anterior, 5.5 mm ventral, 3.5 mm lateral to the bregma) [19, 20] . Autologous whole blood was injected at a rate of 10 μl/min by a microinfusion pump. Sham controls received only an intracerebral needle insertion. After injection, the needle was removed and the skin incision sutured closed.
Experimental Groups
There are two parts of experiments in this study [1] . Male adult Sprague-Dawley rats had either an intracaudate injection of 100 μl autologous whole blood (n = 6 per time point) or a needle insertion (sham, n = 3 per time point) randomly. All animals had T2 and T2* MRI at days 1, 3, and 7, and the brains were used for histology [2] ; SHR (n = 12) or WKY rats (n = 12) had an intracaudate injection of 100 μl autologous whole b l o o d , a n d a l l a n i m a l s h a d T 2 a n d T 2 * M R I . Hematoma formation was confirmed by MRI. No animals were excluded. The animals were euthanized at day 1, 3, or 7, and the brains were used for histology. GW performed the surgeries and MRI, and GD and YY did all the measurements.
Magnetic Resonance Imaging and T2* Lesion Measurement
T2-and T2*-weighted MRI was performed at day 1 and day 3 after ICH or sham operation [21] [22] [23] . Rats were anesthetized with 1.5 % isoflurane/air mixture throughout MRI in a 7.0-T Varian MR scanner (183-mm horizontal bore; Varian) while maintaining body temperature through circulated heated air. A double-tuned volume radiofrequency coil was used to scan the head. The following parameters were used: TR/TE = 4000/ 60 ms for T2 MRI and 200/5 ms for T2* MRI, FOV = 35 × 35 mm 2 , matrix = 256 × 256, slice thickness = 0.5 mm, and slice spacing = 0 mm. Images were analyzed using ImageJ. The T2* lesion was outlined along the border of the hypointense (dark) signal area including the central isointense or hyperintense signal area, and the total T2* lesion volume was obtained over all slices by multiplying the section thickness. The isointense and hyperintense signal area located in the center of the hematoma was outlined on every slice, and the isointense and hyperintense signal volumes were obtained as the non-hypo-T2* lesion.
Brain Histology and H&E Staining
The rats were anesthetized and perfused transcardially with 4 % paraformaldehyde. Their brains were then sectioned on a cryostat (18-μm-thick slices). Hematoxylin and eosin (H&E) staining was performed following a regular protocol [24] and used to demarcate the hematoma. On that staining, hematoma areas were identified as having intact or lysed erythrocytes. The total hematoma area and the erythrolysis area were measured using ImageJ. The degree of hematoma erythrolysis was calculated as (erythrolysis area / hematoma area) × 100 %.
Immunohistochemistry and Immunofluorescence Double Labeling
Immunohistochemistry and immunofluorescence double labeling were performed as described previously [24] [25] [26] . The primary antibodies were rabbit anti-CD163 (1:100 dilution, Abcam), rabbit anti-dopamineand cAMP-regulated phosphoprotein, Mr 32 kDa ( D A R P P -3 2 , 1 : 2 0 0 d i l u t i o n , C e l l S i g n a l i n g Technology), mouse anti-CD11b(OX42) protein (1:100 dilution; AbD, MCA275R), polyclonal rabbit anti-glial fibrillary acidic protein (GFAP) IgG (1:400 dilution; Millipore, MCA360), and mouse anti-neuronal-specific nuclear protein (NeuN) IgG ( positive areas were outlined on three consecutive sections at the blood injection level with a ten-section interval. Neuronal loss was determined for those three sections as follows: (Contralateral − Ipsilateral) / Contralateral DARPP-32-positive area. For CD163-positive cell counting, three images (×40 magnification) were taken in the perihematomal area. DARPP-32 is a reliable marker of striatal neuronal death [24, 27] . All measurements were repeated three times and the mean value was used. 
Statistical Analyses
All data in this study are presented as means ± SD. Data were analyzed with Student's t test, ANOVA, or Spearman's correlation. Differences were considered significant at p < 0.05.
Results
Heterogeneity in Hematoma Appearance on T2*MRI in Sprague-Dawley Rats Both T2-and T2*-weighted imaging can detect the hematoma. On T2-weighted imaging, hematomas had a central hyperintense signal surrounded by a hypointense signal at day 1 ( Fig. 1a; upper panels) . On T2*-weighted imaging, an isointense and hyperintense signal in the center of the hematoma was also observed clearly ( Fig. 1a; lower panels) . The hypointense signal in the periphery of the hematoma was more obvious on T2*-weighted imaging than on T2-weighted imaging. At day 3 or 7 after ICH, a similar appearance pattern was observed (Fig. 1b) . We quantified the ratio of isointense and hyperintense signal volume (non-hypo-T2* lesion volume) to total T2* lesion volume. This was 16 ± 5 % at day 1, 21 ± 10 % at day 3 (Fig. 1c) , and 37 ± 5 % at day 7 after ICH.
Heterogeneity in Hematoma Appearance on H&E Staining in Sprague-Dawley Rats
To determine what pathological changes in the hematoma resulted in the non-hypo-T2* area, H&E staining was performed. In the periphery of hematoma (hypo-T2* lesion area), most erythrocytes had normal disk-shaped profiles and were intensely stained by H&E (Fig. 2) . In contrast, in the center of the hematoma (i.e., non-hypo-T2* area), erythrocytes lost their normal disk shape and most of the erythrocytes were ghosts (small, pale pink, round shape; Fig. 2 ). Figure 2a shows an example of the border between the two areas. These different erythrocyte profiles were found at both day 1 and day 3 (Fig. 2) . We hypothesize that these changes in erythrocyte profile reflect early erythrolysis with the release of intracellular hemoglobin in the center of the hematoma.
Erythrolysis and Neuronal Loss in the Ipsilateral Basal Ganglia
DARPP-32 is a neuronal marker in the basal ganglia [24] . In this study, DARPP-32 staining was used to assess ICHinduced neuronal loss in the ipsilateral basal ganglia. Three sections at different levels of hematoma of each rat were used for H&E staining, and adjacent sections were used for DARPP-32 immunohistochemistry. There was a positive correlation between the degrees of hematoma erythrolysis and neuronal loss (Fig. 3 , r = 0.791, n = 18, p < 0.01). This phenomenon was observed both at day 1 and day 3 after ICH.
Early CD163 Upregulation in the Ipsilateral Basal Ganglia After ICH
CD163 is a hemoglobin scavenger receptor that is proposed to have a role in clearing hemoglobin after erythrolysis. Immunoreactivity of CD163 was upregulated significantly in the ipsilateral basal ganglia after ICH in Sprague-Dawley rats by day 1 (Fig. 4) . CD163-positive cells in the ipsilateral basal ganglia increased to 303 ± 128 cells/mm 2 at day 1 and 453 ± 57 cells/mm 2 at day 3 (p < 0.01; Fig. 4) . Only a few CD163-positive cells were observed in the ipsilateral basal ganglia of sham controls and in the contralateral basal ganglia of ICH. Double labeling showed that the CD163 cells were either microglia, neurons, or astrocytes (Fig. 5) . Heterogeneity in the T2* signal within the hematoma was also observed in SHR and WKY rats. In SHRs, the ratio of nonhypo-T2* lesion volume to total T2* lesion volume was significantly higher than in WKY rats at day 1 (18 ± 5 vs. 8 ± 5 %, p < 0.01) and day 3 (25 ± 4 vs. 21 ± 5 %, p < 0.05, Fig. 6 ). These results suggest that more early erythrolysis occurs in the hematoma in SHR compared to WKY rats.
Greater Neuronal Loss in SHR than in WKY Rats After ICH
In Sprague-Dawley rats, neuronal loss correlated with the degree of hematomal erythrolysis (Fig. 3) . The enhanced erythrolysis in SHR versus WKY rats was also associated with more neuronal loss after ICH as assessed by DARPP-32 staining. At day 1 post-ICH, neuronal loss in SHR was 30 ± 6 %, significantly greater than the 14 ± 4 % in WKY rats (p < 0.05, Fig. 7 ). At day 3, neuronal loss was also more severe in SHR than in WKY rats (38 ± 6 vs. 26 ± 8 %, p < 0.05, Fig. 7 ).
Greater CD163 Upregulation in SHR than in WKY Rats After ICH CD163 immunoreactivity was upregulated in the ipsilateral basal ganglia in both SHR and WKY rats. However, compared to WKY rats, CD163-positive cells were significantly higher in SHRs both at day 1 (290 ± 33 vs. 92 ± 34 cells/mm 
Discussion
There are several findings in this study: (1) As early as the first day after ICH, the center of the hematoma appeared isointense or hyperintense on T2*-weighted MRI, while the rim of the hematoma was hypointense; (2) this corresponded to an area of erythrolysis in the center of the hematoma on H&E; (3) the degree of erythrolysis correlated with the severity of ICHinduced neuronal loss; (4) CD163, a hemoglobin scavenger receptor, levels were upregulated early in the ipsilateral basal ganglia after ICH; and (5) the degree of early erythrolysis, ICH-induced neuronal loss, and CD163 upregulation in the basal ganglia were greater in SHR than in WKY rats.
In the present study, substantial erythrolysis in the hematoma was found by the first day of ICH in the rat models. The main location of early erythrolysis occurred in the center of the hematoma. Erythrocyte lysis results in hemoglobin release. Hemoglobin and its degradation products (e.g., iron) then cause neuronal loss around the clot. It is well known that erythrolysis in the hematoma can cause brain iron overload and delayed brain injury after ICH [1, 6] . The present results suggest that erythrolysis can result in not only delayed brain injury but also early brain damage. Our previous studies have shown that erythrolysis may occur very early after ICH. For example, Perls' positive cells were found in the perihematomal area at the first day after ICH [28] and erythrocyte diameters were significantly decreased at the first 24 h [14] . In a rabbit model of ICH, hemoglobin and heme were found in the perihematomal area at 24 h [29] . Other evidence also indicates early erythrolysis after cerebral hemorrhage. Injection of blood into the subarachnoid space in dogs resulted in hemoglobin in CSF by day 1 and a peak on day 2 [30] . That the erythrolysis might occur first in the core of a hematoma is supported by recent data on iron distribution within the hematoma after an ICH using X-ray fluorescence microscopy in mice. Those data showed higher iron concentrations on the periphery of the hematoma than in the center [31] . Our current study showed a relationship between erythrolysis in the clot and neuronal loss in the perihematomal zone. Future studies should determine the mechanisms of early erythrolysis in the hematoma.
The present data found that early erythrolysis can be detected using T2* MRI. T2* MRI detects both hematoma and iron deposition. Our previous study showed that non-heme iron levels in the perihematomal area were increased with time and reached the peak at day 14 in this rat ICH model [28] . It should also be noted that not only erythrolysis can cause the hyperintense or isointense signal on T2* MRI. For example, hyperintense or isointense signal could be found in the hematoma at the very beginning because clot retraction is not complete and serum accumulates in the clot (Xi, unpublished data) . We chose day 1 and day 3 to measure erythrolysis to avoid serum in the clot in the first several hours and delayed significant iron deposition in the perihematomal area. In the acute stages of ICH, areas of hyperintense or isointense signal in the hematoma on T2* MRI corresponded with areas of erythrolysis on histology. Marked erythrocyte lysis was found in the core of the hematoma with the formation of erythrocyte ghosts. Such ghosts, which result from erythrolysis and loss of hemoglobin, are the post-hemolytic residues of erythrocytes. In ICH patients, hyperintense and isointense signals have also been detected in the center of hematomas by T2* MRI or SWI by the first day [9, 10] . Previous studies have indicated that the heterogeneous T2* and SWI signals in the hematoma are due to changes in hemoglobin oxygenation status [9, 10] . The role of erythrolysis in T2* MRI signal changes in the hematoma should be confirmed in larger ICH animal models and humans. It should also be determined whether or not early erythrolysis within the hematoma occurs in humans.
CD163, a 130 kDa membrane protein, belongs to the Bscavenger receptor cysteine-rich^(SRCR) superfamily class B, and it is expressed in monocytes and macrophages [32] . The best-known role for CD163 is as a scavenger receptor for hemoglobin released from erythrocytes during intravascular hemolysis [12] . CD163 is responsible for clearing hemoglobin both physiologically and pathologically although such clearance may increase greatly during excessive pathological hemolysis [33] . While the function of CD163 in clearing hemoglobin in intravascular hemolysis has been well documented, the role of CD163 in ICH is not fully understood. A recent study in patients undergoing intracerebral hematoma evacuation found that CD163 expression increased around the hematoma after ICH [13] . Consistent with those results, the present study showed upregulation of CD163 around hematoma at the acute stage after ICH in rats. CD163 hemoglobin uptake is mainly in the form of a haptoglobin/hemoglobin complex [34] . Hemoglobin internalized through interaction with CD163 is transferred to endosomes and subsequently degraded to iron, carbon monoxide, and biliverdin by heme oxygenases [35] . Therefore, CD163 may have a significant role in hemoglobin clearance around the hematoma. Our present study found that neurons and astrocytes also can express CD163 in the perihematomal area. Recent studies have shown neuronal CD163 [36, 37] . The role of CD163 in neurons and astrocytes needs to be determined in future studies.
Early hematomal erythrolysis, as assessed on T2* MRI, was more severe in SHR than in WKY rats. Our previous study found that ICH induces greater neuronal death and neurological deficits in SHR than in WKY rats. SHRs also had higher brain ferritin (an iron storage protein) levels and stronger microglia/macrophage activation [16] . More early erythrolysis in hematomas may be the cause of the more severe ICH-induced brain injury in SHRs. Hypertension is a prevalent risk factor for ICH, and erythrocyte abnormalities have been widely reported in clinical and experimental hypertension. In hypertensive patients, erythrocyte deformability is significantly reduced [38] . The impairment mainly arises from altered erythrocyte membrane properties [17] . Hypertensive erythrocytes have an oval shape and display an abnormal membrane skeleton pattern [39] . Increased lipid peroxidation and altered tubulin distribution have also been found in the erythrocytes of hypertensive patients [40, 41] . Moreover, changes in erythrocyte deformability and membrane protein composition have been demonstrated in SHRs [18, 42] . In this study, more severe erythrolysis in SHRs might be caused by the abnormal erythrocyte membrane structure and properties.
In conclusion, erythrolysis initiating at the center of hematoma occurs very early after ICH and upregulates perihematomal CD163. The early erythrolysis in the clot can be detected by T2* MRI. Hypertension facilitates the erythrolysis exacerbating ICH-induced neuronal loss. These results suggest that early erythrolysis in the hematoma and CD163 hemoglobin clearance system are potential targets for ICH treatment.
